BiolineRX hopes for breakthrough with schizophrenia drug
CEO Dr. Kinneret Savitzky: Good interim results could speed up talks with potential partners for developing the drug.
By GALI WEINREB/GLOBES
Published: FEBRUARY 11, 2013 23:16
Advertisement
var articleID = window.location.pathname.substring( window.location.pathname.lastIndexOf("-")+1);
var articlesWithoutLinkPremium = ["661248", "661185", "661893", "665206", "602479"];
if( articlesWithoutLinkPremium.includes(articleID) == true)
{
document.getElementById("premium-link").style.display = "none";
}
var cont = `Sign up for The Jerusalem Post Premium Plus for just $5 Upgrade your reading experience with an ad-free environment and exclusive content
